Fair John A 4
4 · Dare Bioscience, Inc. · Filed Jan 26, 2023
Insider Transaction Report
Form 4
Fair John A
Chief Strategy Officer
Transactions
- Award
Stock Option (right to buy)
2023-01-24+290,000→ 290,000 totalExercise: $1.16Exp: 2033-01-24→ Common stock (290,000 underlying)
Footnotes (1)
- [F1]This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.